Research Partnership is delighted to be attending the Eyeforpharma Real World Evidence (RWE) conference in Tokyo, Japan 16-17 May. RWE is currently a very hot topic for the Japanese pharma industry, with an increased push to place RWE as a strategic imperative for pharma. Representing Research Partnership is APAC Director, Pei Li Teh who is based in the company’s Asia-Pacific office in Singapore. Find out more: https://bit.ly/2rcxf7Q
How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider. Research Partnership